SCHEMBL4331801

SCHEMBL4331801

CC(C)C(O)(Cl)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.46
CYP2D6 P10635 3/20 0.45
CYP1A2 P05177 3/20 0.45
CYP2C19 P33261 4/20 0.42
ALDH1A1 P00352 4/20 0.42
HSD17B10 Q99714 1/20 0.42
KCNA5 P22460 1/20 0.40
CYP3A4 P08684 3/20 0.39
CRHBP P24387 1/20 0.39
CRHR2 Q13324 1/20 0.39
HIF1A Q16665 1/20 0.39
KDM4E B2RXH2 1/20 0.38
ALOX15 P16050 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
TTR P02766 1/20 0.37
ESR1 P03372 2/20 0.37
ESR2 Q92731 2/20 0.37
CYP2C9 P11712 1/20 0.37
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8733990 0.82 CYP1A2 (0.42) TSHRCYP2D6CYP1A2CYP2C19ALDH1A1
SCHEMBL28790233 0.82 TSHR (0.42) TSHRCYP2D6CYP1A2CYP2C19ALDH1A1
SCHEMBL3364003 0.79 CYP2D6 (0.42) TSHRCYP2D6CYP1A2CYP2C19ALDH1A1
SCHEMBL28399440 0.76 TSHR (0.46) TSHRCYP2D6CYP1A2CYP2C19ALDH1A1
SCHEMBL8089565 0.75 TSHR (0.50) TSHRCYP2D6CYP1A2CYP2C19ALDH1A1
SCHEMBL6470482 0.75 CYP2C19 (0.55) CYP2D6CYP1A2CYP2C19ALDH1A1HSD17B10
SCHEMBL29608887 0.75 CYP2D6 (0.48) CYP2D6CYP1A2CYP2C19ALDH1A1HSD17B10
SCHEMBL28175240 0.75 TSHR (0.50) TSHRCYP2D6CYP1A2CYP2C19ALDH1A1
SCHEMBL9723670 0.75 CYP2D6 (0.48) CYP2D6CYP1A2CYP2C19ALDH1A1HSD17B10
SCHEMBL3959121 0.73 CYP2D6 (0.47) CYP2D6CYP1A2CYP2C19ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed
CN-1236612-A Methods and compositions for protecting animals and humans against attack and infestation by arthropod and helminth parasites AMERICAN CYANAMID CO (US) 1999-12-01 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 TSHR 532/4885CYP2D6 331/4885CYP1A2 1508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.